Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 111 Pages
Report ld: 4618996
Request Sample
Customized Report
Patient Repositioning System Market Size(US$)

CAGR 2025-2031
6.8%
Market Size,2031
USD 690
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Patient Repositioning System was estimated to be worth US$ 438 million in 2024 and is forecast to a readjusted size of US$ 690 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
A Patient Repositioning System is a set of equipment and procedures designed to safely and effectively change a patient's body position within a healthcare setting. Repositioning, that is a change in the individual's position whether by themselves or assisted (with or without the use of equipment) is an accepted method of pressure ulcer prevention.
North American market for Patient Repositioning System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Patient Repositioning System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Patient Repositioning System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Patient Repositioning System include The Morel Company, Stryker, Medline, Arjo, Mölnlycke, Ansell, Seneca Devices, Vendlet, HoverTech, Bridge Healthcare, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Patient Repositioning System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Patient Repositioning System by region & country, by Type, and by Application.
The Patient Repositioning System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patient Repositioning System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Patient Repositioning System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Patient Repositioning System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Patient Repositioning System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Patient Repositioning System Product Introduction
1.2 Global Patient Repositioning System Market Size Forecast
1.2.1 Global Patient Repositioning System Sales Value (2020-2031)
1.2.2 Global Patient Repositioning System Sales Volume (2020-2031)
1.2.3 Global Patient Repositioning System Sales Price (2020-2031)
1.3 Patient Repositioning System Market Trends & Drivers
1.3.1 Patient Repositioning System Industry Trends
1.3.2 Patient Repositioning System Market Drivers & Opportunity
1.3.3 Patient Repositioning System Market Challenges
1.3.4 Patient Repositioning System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Patient Repositioning System Players Revenue Ranking (2024)
2.2 Global Patient Repositioning System Revenue by Company (2020-2025)
2.3 Global Patient Repositioning System Players Sales Volume Ranking (2024)
2.4 Global Patient Repositioning System Sales Volume by Company Players (2020-2025)
2.5 Global Patient Repositioning System Average Price by Company (2020-2025)
2.6 Key Manufacturers Patient Repositioning System Manufacturing Base and Headquarters
2.7 Key Manufacturers Patient Repositioning System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Patient Repositioning System
2.9 Patient Repositioning System Market Competitive Analysis
2.9.1 Patient Repositioning System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Patient Repositioning System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient Repositioning System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sliding Sheet
3.1.2 Air-assisted Mattress
3.1.3 Electronic Repositioning System
3.1.4 Others
3.2 Global Patient Repositioning System Sales Value by Type
3.2.1 Global Patient Repositioning System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Patient Repositioning System Sales Value, by Type (2020-2031)
3.2.3 Global Patient Repositioning System Sales Value, by Type (%) (2020-2031)
3.3 Global Patient Repositioning System Sales Volume by Type
3.3.1 Global Patient Repositioning System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Patient Repositioning System Sales Volume, by Type (2020-2031)
3.3.3 Global Patient Repositioning System Sales Volume, by Type (%) (2020-2031)
3.4 Global Patient Repositioning System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Nursing Home
4.1.3 Rehabilitation Center
4.1.4 Others
4.2 Global Patient Repositioning System Sales Value by Application
4.2.1 Global Patient Repositioning System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Patient Repositioning System Sales Value, by Application (2020-2031)
4.2.3 Global Patient Repositioning System Sales Value, by Application (%) (2020-2031)
4.3 Global Patient Repositioning System Sales Volume by Application
4.3.1 Global Patient Repositioning System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Patient Repositioning System Sales Volume, by Application (2020-2031)
4.3.3 Global Patient Repositioning System Sales Volume, by Application (%) (2020-2031)
4.4 Global Patient Repositioning System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Patient Repositioning System Sales Value by Region
5.1.1 Global Patient Repositioning System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Patient Repositioning System Sales Value by Region (2020-2025)
5.1.3 Global Patient Repositioning System Sales Value by Region (2026-2031)
5.1.4 Global Patient Repositioning System Sales Value by Region (%), (2020-2031)
5.2 Global Patient Repositioning System Sales Volume by Region
5.2.1 Global Patient Repositioning System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Patient Repositioning System Sales Volume by Region (2020-2025)
5.2.3 Global Patient Repositioning System Sales Volume by Region (2026-2031)
5.2.4 Global Patient Repositioning System Sales Volume by Region (%), (2020-2031)
5.3 Global Patient Repositioning System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Patient Repositioning System Sales Value, 2020-2031
5.4.2 North America Patient Repositioning System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Patient Repositioning System Sales Value, 2020-2031
5.5.2 Europe Patient Repositioning System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Patient Repositioning System Sales Value, 2020-2031
5.6.2 Asia Pacific Patient Repositioning System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Patient Repositioning System Sales Value, 2020-2031
5.7.2 South America Patient Repositioning System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Patient Repositioning System Sales Value, 2020-2031
5.8.2 Middle East & Africa Patient Repositioning System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Patient Repositioning System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Patient Repositioning System Sales Value and Sales Volume
6.2.1 Key Countries/Regions Patient Repositioning System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Patient Repositioning System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Patient Repositioning System Sales Value, 2020-2031
6.3.2 United States Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Patient Repositioning System Sales Value, 2020-2031
6.4.2 Europe Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Patient Repositioning System Sales Value, 2020-2031
6.5.2 China Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Patient Repositioning System Sales Value, 2020-2031
6.6.2 Japan Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Patient Repositioning System Sales Value, 2020-2031
6.7.2 South Korea Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Patient Repositioning System Sales Value, 2020-2031
6.8.2 Southeast Asia Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Patient Repositioning System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Patient Repositioning System Sales Value, 2020-2031
6.9.2 India Patient Repositioning System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Patient Repositioning System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 The Morel Company
7.1.1 The Morel Company Company Information
7.1.2 The Morel Company Introduction and Business Overview
7.1.3 The Morel Company Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 The Morel Company Patient Repositioning System Product Offerings
7.1.5 The Morel Company Recent Development
7.2 Stryker
7.2.1 Stryker Company Information
7.2.2 Stryker Introduction and Business Overview
7.2.3 Stryker Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Stryker Patient Repositioning System Product Offerings
7.2.5 Stryker Recent Development
7.3 Medline
7.3.1 Medline Company Information
7.3.2 Medline Introduction and Business Overview
7.3.3 Medline Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Medline Patient Repositioning System Product Offerings
7.3.5 Medline Recent Development
7.4 Arjo
7.4.1 Arjo Company Information
7.4.2 Arjo Introduction and Business Overview
7.4.3 Arjo Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Arjo Patient Repositioning System Product Offerings
7.4.5 Arjo Recent Development
7.5 Mölnlycke
7.5.1 Mölnlycke Company Information
7.5.2 Mölnlycke Introduction and Business Overview
7.5.3 Mölnlycke Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Mölnlycke Patient Repositioning System Product Offerings
7.5.5 Mölnlycke Recent Development
7.6 Ansell
7.6.1 Ansell Company Information
7.6.2 Ansell Introduction and Business Overview
7.6.3 Ansell Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ansell Patient Repositioning System Product Offerings
7.6.5 Ansell Recent Development
7.7 Seneca Devices
7.7.1 Seneca Devices Company Information
7.7.2 Seneca Devices Introduction and Business Overview
7.7.3 Seneca Devices Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Seneca Devices Patient Repositioning System Product Offerings
7.7.5 Seneca Devices Recent Development
7.8 Vendlet
7.8.1 Vendlet Company Information
7.8.2 Vendlet Introduction and Business Overview
7.8.3 Vendlet Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Vendlet Patient Repositioning System Product Offerings
7.8.5 Vendlet Recent Development
7.9 HoverTech
7.9.1 HoverTech Company Information
7.9.2 HoverTech Introduction and Business Overview
7.9.3 HoverTech Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 HoverTech Patient Repositioning System Product Offerings
7.9.5 HoverTech Recent Development
7.10 Bridge Healthcare
7.10.1 Bridge Healthcare Company Information
7.10.2 Bridge Healthcare Introduction and Business Overview
7.10.3 Bridge Healthcare Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Bridge Healthcare Patient Repositioning System Product Offerings
7.10.5 Bridge Healthcare Recent Development
7.11 EZ Way
7.11.1 EZ Way Company Information
7.11.2 EZ Way Introduction and Business Overview
7.11.3 EZ Way Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 EZ Way Patient Repositioning System Product Offerings
7.11.5 EZ Way Recent Development
7.12 Hill-Rom
7.12.1 Hill-Rom Company Information
7.12.2 Hill-Rom Introduction and Business Overview
7.12.3 Hill-Rom Patient Repositioning System Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Hill-Rom Patient Repositioning System Product Offerings
7.12.5 Hill-Rom Recent Development
8 Industry Chain Analysis
8.1 Patient Repositioning System Industrial Chain
8.2 Patient Repositioning System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Patient Repositioning System Sales Model
8.5.2 Sales Channel
8.5.3 Patient Repositioning System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Patient Repositioning System market is projected to grow from US$ 465 million in 2025 to US$ 732 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 151
USD 4900.00
(Single User License)
The global Patient Repositioning System market size was US$ 465 million in 2025 and is forecast to reach a readjusted size of US$ 732 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 100
USD 4250.00
(Single User License)
The global Patient Repositioning System market was valued at US$ 465 million in 2025 and is anticipated to reach US$ 732 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 2900.00
(Single User License)
The global market for Patient Repositioning System was estimated to be worth US$ 465 million in 2025 and is projected to reach US$ 732 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 119
USD 3950.00
(Single User License)
The global Patient Repositioning System market size was US$ 438 million in 2024 and is forecast to a readjusted size of US$ 690 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
The global Patient Repositioning System market is projected to grow from US$ 438 million in 2024 to US$ 690 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 160
USD 4900.00
(Single User License)
The global market for Patient Repositioning System was valued at US$ 438 million in the year 2024 and is projected to reach a revised size of US$ 690 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
The global Patient Repositioning System market is projected to grow from US$ 438 million in 2024 to US$ 650 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published Date: 2024-11-19
Pages: 157
USD 4900.00
(Single User License)
The global Patient Repositioning System revenue was US$ 409 million in 2023 and is forecast to a readjusted size of US$ 650 million by 2030 with a CAGR of 6.8% during the review period (2024-2030).
Published Date: 2024-11-19
Pages: 130
USD 4350.00
(Single User License)
The global market for Patient Repositioning System was estimated to be worth US$ 409 million in 2023 and is forecast to a readjusted size of US$ 650 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030.
Published Date: 2024-11-19
Pages: 128
USD 3950.00
(Single User License)
The global Patient Repositioning System market is projected to grow from US$ 465 million in 2025 to US$ 732 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 151
The global Patient Repositioning System market size was US$ 465 million in 2025 and is forecast to reach a readjusted size of US$ 732 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 100
The global Patient Repositioning System market was valued at US$ 465 million in 2025 and is anticipated to reach US$ 732 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
The global market for Patient Repositioning System was estimated to be worth US$ 465 million in 2025 and is projected to reach US$ 732 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 119
The global Patient Repositioning System market size was US$ 438 million in 2024 and is forecast to a readjusted size of US$ 690 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
The global Patient Repositioning System market is projected to grow from US$ 438 million in 2024 to US$ 690 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 160
The global market for Patient Repositioning System was valued at US$ 438 million in the year 2024 and is projected to reach a revised size of US$ 690 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-03-10
Pages: 92
The global Patient Repositioning System market is projected to grow from US$ 438 million in 2024 to US$ 650 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2024-11-19
Pages: 157
The global Patient Repositioning System revenue was US$ 409 million in 2023 and is forecast to a readjusted size of US$ 650 million by 2030 with a CAGR of 6.8% during the review period (2024-2030).
Published: 2024-11-19
Pages: 130
The global market for Patient Repositioning System was estimated to be worth US$ 409 million in 2023 and is forecast to a readjusted size of US$ 650 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030.
Published: 2024-11-19
Pages: 128
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now